Pharmacy Podcast Network

Real-Time CGM Use in Pregnancy: A Breakthrough in the Treatment for Your Patients with Diabetes | Real-Time Real Talk by Dexcom

Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information.
 
Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility.
The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy.
Amy Valent, MD is a paid spokesperson for Dexcom and is a guest on this episode of the podcast.
About Hello Dexcom
 
Dexcom Provider website
 
Dexcom’s partners are working to integrate insulin pumps, insulin pens, and digital health apps with Dexcom G7.
Data from collaborator devices and products must be verified by those collaborator devices and products. Users should confirm data and connections with their collaborator devices and products.
 
A separate Follow app and internet connection are required to follow CGM users’ glucose readings and trends. CGM users should always confirm glucose readings on the Dexcom G7 app or receiver before making treatment decisions.
Brief Safety Statement
BRIEF SAFETY STATEMENT: Failure to use the Dexcom G7 Continuous Glucose Monitoring System (G7) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose0 or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G7 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
Dexcom Clarity Safety Information
The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional.
Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries.
References
Dexcom G7 User Guide
Satish K. Garg, MD, et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes.Diabetes Technology & Therapeutics.Jun 2022.373 380.http://doi.org/10.1089/dia.2022.0011.
Denice S Feig, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
 

TWIRx | Technology, Policy, and Pharmacist’s Positioning in Healthcare Reform

We discuss new cloud-based software technology platforms empowering long term care pharmacies for the future and government policy's impact on pharmacists positioning in addiction medicine.
 
Visit Omnipod.com for more information about this episode's sponsor.

Patients More Likely to Fill Meds When Enrolled in MIH-CIP Program | DrFirst

Olufunke Sokan, Pharm.D., advanced practice pharmacist at the University of Maryland School of Pharmacy and lead author of the study to discuss the study findings and how clinicians used tech to monitor prescription fill patterns and counsel patients accordingly.Patients with chronic heart disease and lung disease are more likely to fill their prescriptions when enrolled in a Mobile Integrated Healthcare and Community Paramedicine (MIH-CP) program after hospital discharge according to a new study by the University of Maryland just published this month.
 
Prescription first-fill rates increased by nearly 20% for patients with congestive heart failure (CHF) and 25% for patients with chronic obstructive pulmonary disease (COPD) in the first 30 days after enrollment. The six-month pilot also improved medication adherence by 8% to 14% in the 60 days after a pharmacist-led intervention. Because the improvements did not continue beyond 30-60 days, the study authors suggest that adding additional interventions could achieve an ongoing impact on medication adherence.the press release!

What’s the Middleman Doing? The Need for PBM Transparency | Integra X Files

Ryan Oftebro, PharmD, FACA, CEO of independent Kelley-Ross Pharmacy Group, joins us for an open conversation about pharmacy benefit managers (PBM) fresh off his testimony on Capitol Hill. Oftebro spoke to the Senate Committee on Commerce, Science, and Transportation, during a hearing addressing how the “Pharmacy Benefit Manager Transparency Act” will bring transparency into PBM business practices and prohibit unfair or deceptive PBM conduct.

Part Two: The Opioid Use Disorder Treatment Rx Series | OpioidRx

Biography
Dr. Bratberg is well acquainted with the challenges community pharmacists and pharmacies face regarding opioid safety, overdose, harm reduction, and addiction pharmacotherapy. In 2012, Dr. Bratberg, along with a URI student pharmacist, co-developed an overdose education and naloxone training program for pharmacists in the first-in-nation statewide Collaborative Pharmacy Practice Agreement for naloxone.  
He is an unpaid consultant for prescribetoprevent.org and prevent-protect.org, websites devoted to opioid overdose education and naloxone training for health professionals, community members, and health departments. In 2015, he was selected to serve as a member of the RI Governor’s Overdose Prevention and Intervention Task Force, to create and implement a plan that addresses prevention, treatment, overdose reversal, and recovery of citizens affected by opioid use disorders.
He has been a consultant or co-investigator on federal grants from NIDA, CDC, AHRQ, NIGMS, RI EOHHS, and the URI Foundation. Dr. Bratberg is the 2016 NASPA National Cardinal Health Generation Rx Award winner. The Generation Rx Champions Award honors a pharmacist who has demonstrated outstanding commitment to raising awareness of the dangers of prescription drug misuse among the general public, as well as the pharmacy community. Finally, Dr. Bratberg is the guest editor of the first ever Special Issue on Opioid Safety and Naloxone of the Journal of the American Pharmacists Association (Mar/April 2017).
Reference https://www.statnews.com/2023/02/08/addiction-pregnancy-treatment-not-criminalization/ 

The Opioid Use Disorder Treatment Rx Series | Pharmacy Podcast Network

Ernest Dole
Clinical Pharmacist University of New Mexico Hospitals Albuquerque, New Mexico About: Dr. Dole is Clinical Pharmacist at University of New Mexico Hospitals (UNMH), Department of Clinical Pharmacy/Pain Consultation and Treatment Center (PCTC); and Clinical Associate Professor at University of New Mexico Health Sciences College of Pharmacy. At UNMH PCTC, Dr. Dole manages ambulatory care patients with chronic pain, as well as participating on an inpatient Pain Service. He received his B.S. in Pharmacy from Colorado, with honors, and his Doctor of Pharmacy degree from Tennessee. He completed an ASHP accredited Clinical Pharmacy Practice residency at Memphis VAMC, 1988. Dr. Dole was the ninth Pharmacist Clinician in New Mexico in 1996, was recognized as an ASHP fellow in 1997, passed the Board of Pharmaceutical Specialties Pharmacotherapy exam in 1997, and Certified Diabetes Educator exam in 2000. Dr. Dole has twice been nominated for the NMSHP Pharmacist of the Year. He has been the Chair of American Society of Health-System Pharmacists Section of Home, Ambulatory and Chronic Care Practitioners and has served as a member on ASHP Councils and Task Forces. He has been president of the New Mexico Society of Health-System Pharmacists in 2008-2009. Dr. Dole received the Volunteer Faculty of the Year Award and Preceptor of the Year Award from University of New Mexico Health Sciences College of Pharmacy in 2009. In 2012, Dr. Dole received the Dorothy Dillon Memorial Lecture Award from the New Mexico Society of Health System Pharmacists. This is the organization’s highest honor. In 2013 Dr. Dole received the ASHP Section of Ambulatory Care Practitioners Distinguished Service Award. His research interests include the impact of culture on pharmaceutical care, substance abuse in the elderly, and obtaining federal recognition of pharmacists as healthcare providers. His research interests with respect to chronic pain control include the effect of high opiate doses on testosterone levels, the effect of opiates on sleep apnea, and the use of non-opiate medications in the therapy of chronic non-cancer pain.

Why Authenticity Is Important | The Road To Match Day

Join us for a important conversation about the power of authenticity during interviews. Hear from Dr. Janan Sarwar about the importance of authenticity.

TWIRx | Understanding the Power of Information to Improve Healthcare

Gil Bashe, Chair of Global Health and Purpose at FINN Partners, agrees that connecting data by using technology is the key to unlocking the power of information. Gil had an opportunity to talk with Tom Lawry. Mr. Lawry serves as Director of Worldwide Health for Microsoft. In this role he works with providers and life science organizations in planning and implementing innovative analytical solutions that improve the quality and efficiency of health services delivered around the globe.

The Magnesium Conundrum with Dr. Jesica Mills | Sports Pharmacy Podcast

I am so excited for this treat that we have given YOU, our listener! Dr. Jesica Mills of Owensboro Pharmacy and Wellness sits down with me your host  Dr. H as we dive deep into the Magnesium Conundrum. I highly recommend you sit down, take notes, and absorb all that Dr. Mills has to offer here. We go into each type of magnesium and explain the deficiency and which supplement is right for you! Follow us on social media! @sportspharmacypod and Dr. H at @doctormixalot

Pathways to a Pharmacy Franchise - Part 2 | Cardinal Health™ Counter Talk™ Podcast

In the second of a two-part episode, host Jason Callori talks with JJ Bernabei, Owner of Tri-State Medical Group, about his experiences as a pharmacy owner and his pathway to joining the Medicine Shoppe Franchise. or Medicap Pharmacy Franchise.